Newark, NJ 的 乳癌 臨床試驗
18 項針對 乳癌 的研究正在 Newark（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
招募中3 期
- Summit Health, Florham Park · 距離 12 英里
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Morristown Medical Center, Morristown · 距離 17 英里
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
招募中2 期
- Medical Oncology Hematology Associates, Newark
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
招募中1/2 期
- Summit Medical Group, Florham Park · 距離 12 英里
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
招募中3 期
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Newark
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Livingston · 距離 9 英里
- Summit Medical Group PA, Florham Park · 距離 12 英里
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
招募中3 期
- Summit Medical Group, Florham Park · 距離 12 英里
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
招募中3 期
- Summit Medical Group, Florham Park · 距離 12 英里
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
招募中觀察性研究
- Summit Medical Group, Florham Park · 距離 12 英里
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
招募中3 期
- Newark Beth Israel Medical Center, Newark
- Cooperman Barnabas Medical Center, Livingston · 距離 9 英里
- Morristown Medical Center, Morristown · 距離 17 英里
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
招募中2 期
- GSK Investigational Site, Morristown · 距離 17 英里
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
招募中3 期
- Morristown Medical Center, Morristown · 距離 17 英里
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
招募中
- Rutgers State University of New Jersey Medical School, Newark
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中觀察性研究
- Morristown Medical Center, Morristown · 距離 17 英里
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
招募中
- Summit Health, Florham Park · 距離 12 英里
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
招募中1 期
- RWJBarnabas Health Clara Maas Medical Center, Belleville · 距離 4 英里
- Cooperman Barnabas Medical Center, Livingston · 距離 9 英里
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
招募中2 期
- RWJBarnabas Health - Newark Beth Israel Medical Center, Newark
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
招募中4 期
- Cancer Center Initiative, Newark
- University Hospital, Newark
- RWJBarnabas Health Newark Beth Israel Medical Center, Newark
- 還有 2 項
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
招募中3 期
- Morristown Medical Center, Morristown · 距離 17 英里
其他城市的 乳癌 試驗
- New York City, NY136 項研究
- Houston, TX126 項研究
- Boston, MA112 項研究
- Nashville, TN81 項研究
- Los Angeles, CA73 項研究
- Edison, NJ68 項研究
- St. Louis, MO64 項研究
- Queens, NY64 項研究
- Durham, NC64 項研究
- Chicago, IL59 項研究
- Philadelphia, PA56 項研究
- Dallas, TX55 項研究
Newark 的其他研究
- 脊髓損傷13 項研究
- 非小細胞肺癌13 項研究
- 急性髓系白血病12 項研究
- 心臟衰竭10 項研究
- 轉移性癌症10 項研究
- 心血管疾病9 項研究
- 胰臟癌9 項研究
- 黑色素瘤8 項研究
- 癌症（所有類型）7 項研究
- 肺癌7 項研究
- 克隆氏症7 項研究
- 主動脈瓣狹窄6 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。